Motivating Patient Adherence to Allergic Rhinitis Treatments

Bender, Bruce G.

doi:10.1007/s11882-014-0507-8

Cited by 42 publications

(26 citation statements)

References 63 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Few studies reported the prevalence of adherence in AR patients in the real‐life context. About 35% of patients were non‐adherent for some time during the treatment, and 38% indicated that they discontinued treatment when they felt better . One study, carried out in the outpatient setting, suggests that a short message service (SMS) helps to improve AR treatment …”

Section: Discussionmentioning

confidence: 99%

“…AR can be described as a seasonal condition; therefore, some patients may present persistent symptoms while others may present symptoms only when the allergen is present. On the other hand, above 15 days of VAS reported, patients tend to be more adherent, which may also be a result of more severe symptoms, leading to continuous treatment or to a better adherence in people reporting longer periods of use. It would be important to also study the attitudinal and behavioural clusters of individuals who continue to monitor and treat their AR for more than 15 days.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

Menditto¹,

Costa²,

Midão³

et al. 2019

Clin Experimental Allergy

View full text Add to dashboard Cite

Background: Mobile technology may help to better understand the adherence to treatment. MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries. Objectives:To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App. Methods:An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from 1 January 2016 to 1 August 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach.Results: A total of 12 143 users were registered. A total of 6 949 users reported at least one VAS data recording. Among them, 1 887 users reported ≥7 VAS data.About 1 195 subjects were included in the analysis of adherence. One hundred and thirty-six (11.28%) users were adherent (MPR ≥70% and PDC ≤1.25), 51 (4.23%) were partly adherent (MPR ≥70% and PDC = 1.50) and 176 (14.60%) were switchers. On the other hand, 832 (69.05%) users were non-adherent to medications (MPR <70%). Of those, the largest group was non-adherent to medications and the time interval was increased in 442 (36.68%) users. Conclusion and clinical relevance:Adherence to treatment is low. The relative efficacy of continuous vs on-demand treatment for allergic rhinitis symptoms is still a matter of debate. This study shows an approach for measuring retrospective adherence based on a mobile app. This also represents a novel approach for analysing medication-taking behaviour in a real-world setting. K E Y W O R D S adherence, mHealth, mobile technology, observational study, rhinitis, treatment S U P P O R T I N G I N F O R M A T I O N Additional supporting information may be found online in the Supporting Information section at the end of the article. How to cite this article: Menditto E, Costa E, Midão L, et al. the MASK group. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study. Clin Exp Allergy.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

Menditto¹,

Costa²,

Midão³

et al. 2019

Clin Experimental Allergy

View full text Add to dashboard Cite

show abstract

“…Improvement in the compliance with allergen immunotherapy, therefore, requires multidisciplinary and integral solutions, including patient education, strict follow-up, and regular contacts before and during treatment [33,37]. A consensual agreement between the patient and the specialist to tailor the schedule [38] and establishing a mechanism to remind the patients to take their medication [39,40] should also improve the compliance outcomes. …”

Section: Discussionmentioning

confidence: 99%

Comprehensive Study of Patients’ Compliance with Sublingual Immunotherapy in House Dust Mite Perennial Allergic Rhinitis

Malet¹,

Azpeitia

Gutiérrez

et al. 2016

Adv Ther

View full text Add to dashboard Cite

show abstract

“…This perception does not re ect the real scenario of patients' adherence in the AR settings. In fact, it is widely accepted that adherence in AR patients is very low (25,26,47,48). A recent study, in which compliance was assessed in a real-life setting using a mobile phone App, con rmed that about 70% of the recruited European AR patients are nonadherent to medications (26).…”

Section: Discussionmentioning

confidence: 99%

Physicians’ Prescribing Behaviour and Clinical Practice Patterns for Allergic Rhinitis Management in Italy

Passalacqua

Musarra²,

Senna

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Despite availability of clinical guidelines, underdiagnosis, undertreatment, and poor adherence are still significant concerns in allergic rhinitis (AR) therapeutic management. We investigated clinical practice patterns and prescribing behavior of Italian healthcare professionals (HCPs) specialized in AR management. Methods: One-hundred allergologists, 100 ear, nose and throat (ENT) specialists, and 150 general practitioners (GPs) were recruited. The survey assessed: socio-demographic, work experience, monthly caseload, prescription drivers. Next, HCPs were invited to retrospectively recover patients’ clinical data to investigate: AR clinical characteristics, therapy management, prescription patterns, patient adherence. Descriptive statistics, Chi-square, One-Way analysis of variance, and Two-Way Analysis of Variance were performed.Results: Allergologists visited more AR patients (31% of monthly caseload) than ENTs (21%, p<0.001), while GPs’ caseload was the lowest (6%). Clinical information of 2823 patients were retrieved of whom 1906 (67,5%) suffered from moderate/severe AR (discomfort score: 7,7±1,3) and 917 (32,4%) from mild AR (5.7±1.9). About one-third of mild patients had a discomfort score >=7. Main prescription drivers were “effective on all symptoms” (54,3% patients) and “quick symptom relief” (47,8%), whereas minor drivers were “affordable price” (13,4%) and “refundable” (8,7%). The most prescribed drugs were antihistamines and intranasal corticosteroids (79% and 55% prescriptions), followed by fixed-dose-combination of intranasal azelastine/fluticasone (19%). Polytherapy was the most common treatment strategy (59,6%). HCPs’ believe that the majority of the patients was adherent to treatment (88% with score>7).Conclusions: This survey describes AR pharmacological management by Italian physicians. HCPs underestimated AR severity and had a non-realistic perception of patients’ adherence. These findings suggest that further efforts are required to improve AR clinical management in Italy.

show abstract

Motivating Patient Adherence to Allergic Rhinitis Treatments

Cited by 42 publications

References 63 publications

Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

Comprehensive Study of Patients’ Compliance with Sublingual Immunotherapy in House Dust Mite Perennial Allergic Rhinitis

Physicians’ Prescribing Behaviour and Clinical Practice Patterns for Allergic Rhinitis Management in Italy

Contact Info

Product

Resources

About